These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4440516

  • 1. Successful immunosuppressive treatment of oliguric extracapillary glomerulonephritis.
    Jensen H, Olgaard K, Faarup P.
    Acta Med Scand; 1974 Nov; 196(5):383-6. PubMed ID: 4440516
    [No Abstract] [Full Text] [Related]

  • 2. Structural changes in kidneys of patients with oliguric extracapillary glomerulonephritis during immunosuppressive therapy.
    Faarup P, Nørgaard T, Elling F, Jensen H.
    Acta Pathol Microbiol Scand A; 1978 Sep; 86A(5):409-14. PubMed ID: 362806
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive therapy of proliferative glomerulonephritis in children.
    Urizar RE, Tinglof B, McIntosh R, Litman N, Barnett E, Wilkerson J, Smith F, Vernier RL.
    Am J Dis Child; 1969 Sep; 118(3):411-25. PubMed ID: 4896973
    [No Abstract] [Full Text] [Related]

  • 4. The effect of azathioprine on lupus glomerulonephritis.
    Hayslett JP, Kashgarian M, Cook CD, Spargo BH.
    Medicine (Baltimore); 1972 Sep; 51(5):393-412. PubMed ID: 4115512
    [No Abstract] [Full Text] [Related]

  • 5. Hypocomplementemic (membranoproliferative) glomerulonephritis. Immunosuppressive therapy.
    Holland NH, Bennett NM.
    Am J Dis Child; 1972 May; 123(5):439-45. PubMed ID: 5026213
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H.
    Munch Med Wochenschr; 1969 Aug 29; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC.
    Ann Intern Med; 1972 Dec 29; 77(6):829-35. PubMed ID: 4566283
    [No Abstract] [Full Text] [Related]

  • 8. [Monitoring of the clinical and morphological course of glomerulonephritis].
    Pap I, Kemnitz P, Willgeroth Ch.
    Z Urol Nephrol; 1978 Jun 29; 71(6):369-74. PubMed ID: 685514
    [Abstract] [Full Text] [Related]

  • 9. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V, Natusch R, Göbel U, Laske HR, Sperschneider H, Pap I, Sinn W, Koall W, Achenbach H, Tredt HJ.
    Z Urol Nephrol; 1985 Jan 29; 78(1):39-55. PubMed ID: 3976309
    [Abstract] [Full Text] [Related]

  • 10. Immunopathological changes during immunosuppressive treatment of glomerulonephritis in systemic lupus erythematosus.
    Munthe E, Brodwall EK, Oyri A, Natvig JB.
    Acta Med Scand; 1974 Oct 29; 196(4):291-9. PubMed ID: 4139879
    [No Abstract] [Full Text] [Related]

  • 11. Deterioration of renal function after discontinuation of long-term prednisone-azathioprine therapy in primary renal disease.
    Levitt JI.
    N Engl J Med; 1970 May 14; 282(20):1125-7. PubMed ID: 5439410
    [No Abstract] [Full Text] [Related]

  • 12. Letter: Immunosuppressive treatment of rapidly progressive glomerulonephritis.
    Jensen H, Faarup P, Thaysen JH, Olgaard K.
    Lancet; 1974 Dec 28; 2(7896):1572. PubMed ID: 4141008
    [No Abstract] [Full Text] [Related]

  • 13. [Delayed healing process and exacerbation of a diffuse intra- and extracapillary glomerulonephritis with IgA-deposits (clinical, light-, electron- and immunofluorescent-microscopic examinations of sequential biopsies)].
    Zollinger HU, Gaboardi F.
    Virchows Arch A Pathol Pathol Anat; 1971 Dec 28; 354(4):349-60. PubMed ID: 5316274
    [No Abstract] [Full Text] [Related]

  • 14. [Indications and limitations of immunodepressive therapy in glomerular nephropathies. Initial morphologic and functional findings and changes in the level of some plasma proteins].
    Scarpioni L, Maiorca R, Cambi V, Carrara GC, Dall'Aglio P.
    Minerva Nefrol; 1969 Dec 28; 16(2):157-62. PubMed ID: 5398501
    [No Abstract] [Full Text] [Related]

  • 15. Controlled trial of azathioprine and prednisone in chronic renal disease. Report by Medical Research Council Working Party.
    Medical Research Council Working Party.
    Br Med J; 1971 May 01; 2(5756):239-41. PubMed ID: 4929367
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
    White RH, Cameron JS, Trounce JR.
    Br Med J; 1966 Oct 08; 2(5518):853-60. PubMed ID: 5917404
    [No Abstract] [Full Text] [Related]

  • 17. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA, Olmos A, Ferrer E, Mauri JM, Capdevilla L, Codina S, Alsina J, Camps J, Piera L.
    Rev Clin Esp; 1975 Dec 15; 139(5):415-22. PubMed ID: 1215585
    [No Abstract] [Full Text] [Related]

  • 18. Impact of heavy proteinuria (>1 g/d) following renal transplantation.
    Kim SC, Kang CH, Kim SK, Jang HJ, Kim TH, Jung JG, Han DJ.
    Transplant Proc; 2000 Nov 15; 32(7):1894-5. PubMed ID: 11119989
    [No Abstract] [Full Text] [Related]

  • 19. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C, Brancaccio D, Locatelli F, Imbasciati E.
    Minerva Nefrol; 1969 Nov 15; 16(3):228-34. PubMed ID: 5356052
    [No Abstract] [Full Text] [Related]

  • 20. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 Nov 15; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.